Leaflet: information for theuser
Oxcarbazepinepe600 mg film-coated tablets EFG
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the leaflet
What isOxcarbazepinePe
The active ingredient of Oxcarbazepine Pe is oxcarbazepine.
Oxcarbazepine belongs to the group of medications called anticonvulsants or antiepileptics.
What it is used forOxcarbazepinePe
Medications like oxcarbazepine are the standard treatment for epilepsy.
Patients diagnosed with epilepsy have suffered repeated seizures or convulsions. Seizures occur due to a temporary failure in the brain's electrical system. Normally, brain cells coordinate body movements by sending signals through muscle nerves in an orderly organized manner. The result can be uncoordinated muscle activity known as an epileptic seizure.
Oxcarbazepine is used to treat partial epileptic seizures with or without secondary generalization with tonic-clonic seizures. Partial seizures affect a limited area of the brain but can spread to the entire brain and produce generalized tonic-clonic seizures. There are 2 types of partial seizures: simple and complex. In simple partial seizures, the patient remains conscious, while in complex seizures, the state of consciousness is altered.
Oxcarbazepine works by keeping the "overexcited" nerve cells in the brain under control, thus suppressing or reducing the frequency of such seizures.
Oxcarbazepine can be used alone or in combination with other antiepileptic medications. Normally, your doctor will try to find the medication that works best for you or your child; however, in severe epilepsy, you may need a combination of two or more medications to control seizures. Oxcarbazepine is indicated for use in adults and children 6 years of age or older.
Follow your doctor's instructions carefully, even if they differ from those indicated in this leaflet.
Monitoring during treatment with Oxcarbazepine Pe
Before and during treatment with Oxcarbazepine Pe, your doctor may perform a blood test to establish your dose. Your doctor will tell you when to have the tests.
Do not takeOxcarbazepinePe
If you are allergic to oxcarbazepine or eslicarbazepine or any of the other components of this medication (listed in section 6).
If you are allergic, inform your doctor before taking Oxcarbazepine Pe. If you think you are allergic, ask your doctor.
Warnings and precautions
Consult your doctor or pharmacist or nurse before starting to take Oxcarbazepine Pe:
Inform your doctor immediately if you have irregular or spotting vaginal bleeding. If you have any doubts about this, consult your doctor before taking Oxcarbazepine Pe:
The risk of serious skin reactions in Han Chinese or Thai patients associated with carbamazepine or chemically related compounds can be predicted by blood tests in these patients. Your doctor will advise you if a blood test is necessary before taking oxcarbazepine.
If you notice any of the following symptoms after taking Oxcarbazepine Pe, inform your doctor immediately or go to the Emergency Department of the nearest hospital:
Children and adolescents
For treatment in children, your doctor may recommend monitoring thyroid function before and during treatment.
Use ofOxcarbazepinePewithother medications
Please consult your doctor or pharmacist if you are taking or have recently taken or may need to take any other medication.
Especially in the case of:
TakingOxcarbazepinePewith food, drinks, and alcohol
Oxcarbazepine Pe can be taken with or without food. During treatment with Oxcarbazepine Pe, avoid taking alcoholic beverages, as they may increase the sedative effects of this medication. If in doubt, consult your doctor.
Pregnancy, breastfeeding, and fertility
PregnancyIf you are pregnant or think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication.
It is essential to control seizures during pregnancy. However, there may be a risk to your baby if you take antiepileptic medications during pregnancy.
Birth weight
If you use oxcarbazepine during pregnancy, your child may have a small size and weigh less than expected at birth [small size for gestational age (SGA)]. Among women with epilepsy, in one study, about 15 out of 100 children born to mothers who had taken oxcarbazepine during pregnancy were smaller and weighed less than expected at birth, compared to about 11 out of 100 children born to women who had not taken anticonvulsant medication during pregnancy.
Congenital malformations
Studies have not shown an increased risk of congenital malformations associated with oxcarbazepine administered during pregnancy; however, it cannot be entirely ruled out that there is a risk of congenital malformations in the fetus.
Neurodevelopmental disorders
Some studies have shown that exposure to oxcarbazepine in the womb affects the development of brain function (neurodevelopmental development) in children, while in other studies, this effect has not been observed. The possibility that there is an effect on neurodevelopmental development cannot be ruled out.
Your doctor will inform you of the benefits and possible risks of treatment and help you decide whether you should take Oxcarbazepine Pe.
Do not stop your treatment with oxcarbazepine during pregnancy without consulting your doctor first.
BreastfeedingIf you are taking this medication, consult your doctor before starting breastfeeding.The active ingredient of Oxcarbazepine Pe passes into breast milk. Although the available data suggest that the amount of Oxcarbazepine Pe that passes to the breastfed child is low, a risk of side effects in the baby cannot be ruled out.
Your doctor will inform you of the benefits and potential risks of breastfeeding while using Oxcarbazepine Pe. If you are breastfeeding during treatment with Oxcarbazepine Pe and think your baby is experiencing any side effects such as excessive sleepiness or poor weight gain, inform your doctor immediately.
Driving and using machines
Oxcarbazepine may cause symptoms such as drowsiness, dizziness, or vision changes, and may reduce your reaction ability. These effects, as well as the disease itself, may impair your ability to drive vehicles or operate machines. Therefore, do not drive, operate machines, or engage in other activities that require special attention until your doctor assesses your response to this medication.
It is essential to consult your doctor if you can drive or operate machines while taking this medication.
Follow your doctor's or pharmacist's administration instructions for this medication exactly. If in doubt, consult your doctor or pharmacist again.
How much to take
Use in adults
Use in children
Oxcarbazepine Pe can be used in children 6 years of age or older.
The recommended dose for children will be calculated by the doctor and depends on weight.
How to takeOxcarbazepinePe
When and for how long to takeOxcarbazepinePe
Take oxcarbazepine twice a day, every day, approximately at the same time of day, unless your doctor tells you otherwise. This will have the best effect on controlling epilepsy. It will also help you remember when to take the tablet or tablets.
Your doctor will inform you how long your treatment or your child's treatment will last. The duration of treatment is based on the type of seizures you or your child suffer from and may require continued treatment for several years to control epileptic seizures. Do not change the dose or stop treatment without talking to your doctor first.
If you take moreOxcarbazepinePethan you should
If you have taken many more tablets than your doctor prescribed, inform your doctor or go to the nearest hospital.
The symptoms of oxcarbazepine overdose may include:
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to takeOxcarbazepinePe
If you have forgotten a single dose, take it as soon as you can, except if it is almost time for the next dose; in this case, wait and return to your usual administration schedule. Do not take a double dose to make up for forgotten doses.
If you are unsure or have forgotten several doses, inform your doctor.
If you stop treatment withOxcarbazepinePe
Do not stop taking your medication without consulting your doctor first.
To prevent a sudden worsening of seizures, do not stop treatment abruptly. If you stop your treatment, it should be done gradually as your doctor has indicated.
If you have any other doubts about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Tell your doctor immediately or go to the emergency department of the nearest hospital if you experience any of the following adverse effects:
The following symptoms are very rare (may affect up to 1 in 10,000 people), but they are potentially serious adverse effects that may require urgent medical treatment.
Your doctor will decide whether to immediately stop treatment with Oxcarbazepina Pensa and how to continue your treatment in the future.
Tell your doctor as soon as possible if you experience any of the following adverse effects.They may require medical attention :
Frequent(may affect up to 1 in 10 people):
Very rare(may affect up to 1 in 10,000 people):
Other adverse effects that may occur:
These are mild to moderate adverse effects of Oxcarbazepina Pensa. Most of these effects are temporary and usually decrease over time.
Very frequent(may affect more than 1 in 10 people):
Frequent(may affect up to 1 in 10 people):
Infrequent(may affect up to 1 in 100 people):
Unknown frequency(frequency cannot be estimated from available data):
There have been reports of bone disorders, including osteopenia and osteoporosis (decrease in bone mass), and fractures. Tell your doctor or pharmacist if you have been taking antiepileptics for a long time, have a medical history of osteoporosis, or are taking steroids.
Reporting adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use website: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use after the expiration date indicated on the box and blister as CAD. The expiration date refers to the last day of the month indicated.
Do not use Oxcarbazepina Pensa if the packaging is damaged or shows signs of tampering.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition ofOxcarbazepinaPensa
The active ingredient is oxcarbazepina. Each coated tablet contains 600 mg of oxcarbazepina.
The other components are microcrystalline cellulose, povidone K30, crospovidone, anhydrous colloidal silica, and magnesium stearate in the tablet core; and Opadry white Y-1-7000 (hypromellose, titanium dioxide (E171), macrogol PEG 400) and red iron oxide (E172) in the tablet coating.
Appearance of the product and package contents
The 600 mg tablet is coated, oblong, biconvex, and light pink in color.
The coated tablets are available in blister packs containing 50, 100, and/or 500 tablets.
Only some package sizes may be marketed.
Marketing authorization holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer
Laboratorios Cinfa, S.A.
C/Olaz-Chipi, 10 - Polígono Industrial Areta.
31620 Huarte - Pamplona (Navarra) - Spain
This prospectus was approved in: June 2025
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) www.aemps.gob.es/
The average price of OXCARBAZEPINE PENSA 600 mg FILM-COATED TABLETS in October, 2025 is around 44.12 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.